IP Library Granted Patent US 11,154,057
Granted Patent B2
US 11,154,057 · App. 16/328,885 · Granted Oct 26, 2021

Use of nootkatone to treat mosquito infestations

Inventors: Jean Amick (Lexington, KY); Ryan Murphy (Pewee Valley, KY)
A01N35/06A01N25/04A01N25/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,057
App. No.
16/328,885
Granted
Oct 26, 2021
Kind
B2
Abstract

Compositions and methods for treating and preventing mosquito infestations are disclosed herein. Also disclosed herein are compositions and methods to reduce or prevent the spread of diseases for which mosquitoes may act as a vector.

Claims (15)

1. A method of reducing a mosquito population, comprising:

applying an effective amount of a nootkatone-containing composition to a mosquito breeding site,

wherein the effective amount of the nootkatone-containing composition exposes members of each mosquito life cycle stage to a nootkatone concentration of about 0.01% to 0.03% (v/v) nootkatone at the mosquito breeding site, and

wherein the effective amount of the nootkatone-containing composition kills members of each mosquito life cycle stage at the mosquito breeding site.

2. The method of claim 1 , wherein the nootkatone-containing composition is applied about once per day, about once every 3 days, about once per week, about twice per week, about once per two weeks, about once per month, about once per two months, or about once per three months, or about once per season.

3. The method of claim 2 , wherein the nootkatone-containing composition is applied using a dispenser, wherein the dispenser is a pouch, a puck, a pellet, a block, a granule, a vesicle, or a capsule.

4. The method of claim 3 , wherein the dispenser is refillable.

5. The method of claim 1 , wherein the mosquito population comprises a mosquito of the genera Anopheles, Aedes, Culex , or Haemagogus.

6. The method of claim 5 , wherein the mosquito is Aedes aegypti.

7. The method of claim 1 , wherein the nootkatone is wholly or partially solubilised, liquefied, and/or dispersed in the composition prior to being applied to a mosquito breeding site.

8. The method of claim 7 , wherein the composition comprises ethanol, dichloromethane, ethyl acetate, hexane, an oil, a non-polar solvent, a surfactant, or a mixture or blend thereof.

9. The method of claim 7 , wherein the composition comprises a non-toxic, biodegradable nootkatone-solubilizing carrier or surfactant or a mixture or blend thereof.

10. The method of claim 1 , wherein the nootkatone-containing composition reduces the rate of mosquito egg hatching in the mosquito breeding site.

11. The method of claim 10 , wherein the rate of mosquito egg hatching is reduced by at least about 30%.

12. The method of claim 1 , wherein the members of each mosquito life cycle stage include eggs, larvae, pupae, and adult mosquitoes.

Assignments (2)
MERGER Recorded Jun 27, 2024
From: EVOLVA SA
To: DANSTAR FERMENT AG
Reel/Frame 067863/0857 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2019
From: AMICK, JEAN DAVIN; MURPHY, RYAN MICHAEL
To: EVOLVA SA
Reel/Frame 048507/0806 →
Continuity (2)
Provisional Application 62383077 · Sep 2, 2016
Related Publication 20190208779A1 · Jul 11, 2019